Serum protein marker for early diagnosis of lung cancer
A serum protein and early diagnosis technology, applied in the field of serum protein markers, can solve the problems that human proteins cannot be studied, it is difficult to use clinical disease early diagnosis, lack of protein quantitative technology, etc., to achieve time-sensitive cost, high complexity, pain Reduced effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0013] The specific embodiment of the present invention will be described in further detail below through specific examples.
[0014] A serum protein marker for early diagnosis of lung cancer, wherein the marker is composed of the following components:
[0015] CD44, SCC, CEA, CYFRA21-1, NNMT, CA125, NSE, FDG, TPS, GRP.
[0016] A serum protein marker for early diagnosis of lung cancer, wherein the detection method is:
[0017] Quantitative detection of serum protein was performed by immunomultiple reaction mass spectrometry, the above-mentioned markers were added to the analyte, and the captured samples were eluted using magnetic beads with immobilized anti-polypeptide antibodies and analyzed by MRM-MS to obtain the final detection results.
[0018] For immuno-MRM, biological samples contain abundant peptide analytes, stable isotope-labeled standards are added to the analytes, and the captured samples are eluted using magnetic beads immobilized with anti-peptide antibodies f...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com